Abstract:Effective therapeutic targets against post-myocardial infarction (MI) arrhythmias remain to be discovered. We aimed to investigate the role of macrophages in post-MI arrhythmias. Methods: Mononuclear cell accumulation, macrophage polarization from M0 to M1 subset, and gap junction formation were analyzed in MI patients and MI mice by flow cytometry, immunofluorescence and patch clamping. Differentially expressed genes were identified by RNA sequencing. Macrophages and cardiomyocytes were cocultured in vitro, and the effects of gap junction and KCa3.1 on electrophysiological properties were assessed by patch clamping. The effects of KCa3.1 inhibition on post-MI arrhythmias were assessed by intracardiac stimulation and ambulatory electrocardiograms in vivo. Results: Percentage of pro-inflammatory mononuclear cells were significantly elevated in patients with post-MI arrhythmias compared with MI patients without arrhythmias and healthy controls (p<0.001). Macrophages formed gap junction with cardiomyocytes in MI border zones of MI patient and mice, and pro-inflammatory macrophages were significantly increased 3 days post-MI (p<0.001). RNA sequencing identified Kcnn4 as the most differentially expressed gene encoding ion channel, and the upregulation is mainly attributed to macrophage accumulation and polarization into pro-inflammatory subset. In vitro coculture experiments demonstrated that connection with M0 macrophages via gap junction slightly shortened the action potential durations (APDs) of cardiomyocytes. However, the APD90 of cardiomyocytes connected with M1 macrophages were significantly prolonged (p<0.001), which were effectively attenuated by gap junction inhibition (p=0.002), KCa3.1 inhibition (p=0.008), KCa3.1 silencing (p<0.001) and store-operated Ca2+ channel inhibition (p=0.005). In vivo results demonstrated that KCa3.1 inhibition significantly decreased the QTc durations (p=0.031), intracardiac stimulation-induced ventricular arrhythmia durations (p=0.050) and incidence of premature ventricular contractions (p=0.030) in MI mice. Conclusion: Macrophage polarization leads to APD heterogeneity and post-MI arrhythmias via gap junction and KCa3.1 activation. The results provide evidences of a novel mechanism of post-MI heterogeneous repolarization and arrhythmias, rendering macrophages and KCa3.1 to be potential therapeutic targets.

The Role of Cardiac Macrophage and Cytokines on Ventricular Arrhythmias

Emerging Roles of Macrophages in Heart Failure and Associated Treatment Approaches

The Roles of Macrophages in Heart Regeneration and Repair after Injury

Distinct Origins and Functions of Cardiac Orthotopic Macrophages

Macrophages Facilitate Post Myocardial Infarction Arrhythmias: Roles of Gap Junction and KCa3.1.

Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets

Cross-talk Between Macrophages and Atrial Myocytes in Atrial Fibrillation

New Insights and Novel Therapeutic Potentials for Macrophages in Myocardial Infarction

The Multifaceted Nature of Macrophages in Cardiovascular Disease

Syncytium calcium signaling and macrophage function in the heart

Crosstalk between macrophages and cardiac cells after myocardial infarction

Communications between macrophages and cardiomyocytes

The effect of macrophage-cardiomyocyte interactions on cardiovascular diseases and development of potential drugs

Role of Cardiac Macrophages on Cardiac Inflammation, Fibrosis and Tissue Repair

Macrophages after myocardial infarction: Mechanisms for repairing and potential as therapeutic approaches

Cardiac macrophages in maintaining heart homeostasis and regulating ventricular remodeling of heart diseases

At the heart of inflammation: Unravelling cardiac resident macrophage biology

Cardiac resident macrophages: key regulatory mediators in the aftermath of myocardial infarction

Cardiac resident macrophages: The core of cardiac immune homeostasis

Macrophage-derived VEGF-C reduces cardiac inflammation and prevents heart dysfunction in CVB3-induced viral myocarditis via remodeling cardiac lymphatic vessels

Myeloid Cells in Myocardial Ischemic Injury: The Role of the Macrophage Migration Inhibitory Factor